We are live on ! Find out more
T

TOBAM Portfolio holdings

AUM $384M
1-Year Est. Return 10.32%
This Fund
S&P 500
This Quarter Est. Return
+5.76%
1 Year Est. Return
+10.32%
3 Year Est. Return
+36.67%
5 Year Est. Return
+41.37%
10 Year Est. Return
+233.72%
AUM
$256M
AUM Growth
+$22.2M
Cap. Flow
+$15.1M
Cap. Flow %
5.91%
Top 10 Hldgs %
26.1%
Holding
284
New
33
Increased
92
Reduced
102
Closed
31

Top Buys

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$5.43M
2
ED icon
Consolidated Edison
ED
+$4.83M
3
KR icon
Kroger
KR
+$3.65M
4
EXC icon
Exelon
EXC
+$3.63M
5
AMT icon
American Tower
AMT
+$3.5M

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$4.55M
2
MCK icon
McKesson
MCK
+$2.28M
3
NTNX icon
Nutanix
NTNX
+$1.86M
4
NVDA icon
NVIDIA
NVDA
+$1.79M
5
AKAM icon
Akamai
AKAM
+$1.62M

Sector Composition

Rank Sector Weight
1 Healthcare 21.98%
2 Consumer Staples 20.68%
3 Communication Services 14.33%
4 Financials 11.35%
5 Technology 11.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CBOE icon
1
Cboe Global Markets
CBOE
$29.8B
$7.53M 2.94%
32,283
+944
+3% +$210K
T icon
2
AT&T
T
$165B
$7.5M 2.93%
259,166
+7,932
+3% +$219K
VZ icon
3
Verizon
VZ
$194B
$7.37M 2.87%
170,234
+16,163
+10% +$700K
CHD icon
4
Church & Dwight Co
CHD
$23.1B
$7.35M 2.87%
76,468
+18,618
+32% +$1.84M
HSY icon
5
Hershey
HSY
$35.4B
$7.19M 2.81%
43,312
+4,422
+11% +$729K
ED icon
6
Consolidated Edison
ED
$41.6B
$6.19M 2.41%
61,662
+45,639
+285% +$4.83M
AMT icon
7
American Tower
AMT
$77.7B
$6M 2.34%
27,166
+16,219
+148% +$3.5M
EA icon
8
Electronic Arts
EA
$52.4B
$5.95M 2.32%
37,270
+12,497
+50% +$1.85M
KR icon
9
Kroger
KR
$34.8B
$5.93M 2.31%
82,623
+52,873
+178% +$3.65M
GIS icon
10
General Mills
GIS
$19.2B
$5.87M 2.29%
113,302
+165
+0.1% +$9.11K
CLX icon
11
Clorox
CLX
$11.6B
$5.86M 2.29%
48,784
+7,048
+17% +$940K
WRB icon
12
W.R. Berkley
WRB
$28B
$5.47M 2.13%
74,415
+2,774
+4% +$199K
MSTR icon
13
Strategy Inc
MSTR
$33.5B
$5.4M 2.11%
13,358
-186
-1% -$67.8K
UNH icon
14
UnitedHealth
UNH
$382B
$5.27M 2.06%
16,906
+14,211
+527% +$5.43M
DG icon
15
Dollar General
DG
$25.9B
$5.08M 1.98%
44,404
-8,836
-17% -$877K
EXC icon
16
Exelon
EXC
$48.6B
$4.74M 1.85%
109,102
+81,483
+295% +$3.63M
MCK icon
17
McKesson
MCK
$98.5B
$4.73M 1.85%
6,461
-3,225
-33% -$2.28M
HUM icon
18
Humana
HUM
$46.7B
$4.56M 1.78%
18,664
+9,698
+108% +$2.42M
WST icon
19
West Pharmaceutical
WST
$23.1B
$4.42M 1.72%
20,195
+6,040
+43% +$1.29M
LPLA icon
20
LPL Financial
LPLA
$26.3B
$4.41M 1.72%
11,753
-4,578
-28% -$1.6M
DLTR icon
21
Dollar Tree
DLTR
$23.1B
$4.39M 1.71%
44,318
+21,168
+91% +$1.83M
DXCM icon
22
DexCom
DXCM
$27.6B
$4.34M 1.69%
49,755
+3,514
+8% +$275K
GOOGL icon
23
Alphabet (Google) Class A
GOOGL
$3.91T
$4.18M 1.63%
23,735
+10,051
+73% +$1.65M
AVGO icon
24
Broadcom
AVGO
$1.82T
$4.12M 1.61%
14,934
-2,614
-15% -$568K
NEM icon
25
Newmont
NEM
$98.2B
$4.08M 1.59%
70,115
+29,031
+71% +$1.55M

Similar funds

TOBAM's Q2 2025 Portfolio in Review

As of Q2 2025, TOBAM held 284 positions worth $256M, up 9.5% from $234M the previous quarter. Its ten largest holdings account for 26% of the portfolio.

TOBAM deployed $15.1M of net new capital in Q2 2025, opening 33 new positions and adding to 92 existing holdings. Its largest new stake was D.R. Horton: 15,865 shares worth $2.04M.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 25% a quarter earlier, followed by Consumer Staples and Communication Services.

On the sell side, the largest reduction was AbbVie, an estimated $4.55M trimmed.

  • TOBAM's largest Q2 2025 buy was D.R. Horton: 15,865 shares worth $2.04M.
  • TOBAM added most to UnitedHealth in Q2 2025, an estimated $5.43M increase.
  • TOBAM's biggest Q2 2025 reduction was AbbVie, cutting an estimated $4.55M.
  • TOBAM fully exited International Flavors & Fragrances in Q2 2025, selling an estimated $775K.
  • TOBAM's ten largest holdings make up 26% of its $256M portfolio in Q2 2025.
  • TOBAM opened 33 new positions and closed 31 in Q2 2025.
  • TOBAM's portfolio value rose 9.5% quarter-over-quarter to $256M.

Based on TOBAM's 13F filing for Q2 2025, filed 8 Aug 2025.